Pure Global

Acute Clinical Outcomes of Hemorrhagic Myocardial Infarction - Trial NCT06110351

Access comprehensive clinical trial information for NCT06110351 through Pure Global AI's free database. This phase not specified trial is sponsored by Rohan Dharmakumar and is currently Recruiting. The study focuses on Acute Myocardial Infarction. Target enrollment is 100000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06110351
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT06110351
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Acute Clinical Outcomes of Hemorrhagic Myocardial Infarction

Study Focus

Observational

Sponsor & Location

Rohan Dharmakumar

Indiana University

Indianapolis, United States of America

Timeline & Enrollment

N/A

Nov 01, 2023

Jan 31, 2024

100000 participants

Primary Outcome

Mortality

Summary

Acute clinical outcomes 1. Mortality 2. Arrhythmia 3. Readmission 4. CVA 5. ADHF

ICD-10 Classifications

Acute myocardial infarction
Acute myocardial infarction, unspecified
Acute subendocardial myocardial infarction
Certain current complications following acute myocardial infarction
Other current complications following acute myocardial infarction

Data Source

ClinicalTrials.gov

NCT06110351

Non-Device Trial